| 2012 | Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.
| BMC GENOMICS |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2010 | Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2007 | Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer | GENOMICS |
| 2010 | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Identification of significant regional genetic variations using continuous CNV values in aCGH data | GENOMICS |
| 2019 | Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
| Journal of Rheumatic Diseases |
| 2022 | Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis
| CANCERS |
| 2008 | Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
| BMC BIOINFORMATICS |
| 2009 | In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer | GENOMICS |
| 2009 | Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2014 | Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer | JOURNAL OF PSYCHOSOMATIC RESEARCH |
| 2003 | Infusional Fluorouracil, Etoposide, and Cisplatin (FEP) in Advanced and Relapsed Gastric Cancer | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2007 | Integrated in silico and biological validation of the blocking effect of C(o)t-1 DNA on microarray-CGH | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2006 | Intermediate Dose 5-Fluorouracil-Induced Encephalopathy
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2007 | Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2010 | Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine? | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2001 | Leptomeningeal Carcinomatosis in Solid Tumors ; Clinical Manifestation and Treatment
| Journal of the Korean Cancer Association (대한암학회지) |
| 2006 | Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports
| CANCER RESEARCH AND TREATMENT |
| 2020 | MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
| 2013 | Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2012 | Methylation status of lamin A/C in gastric cancer cell lines | HEPATO-GASTROENTEROLOGY |
| 2011 | MMP-2 as a putative biomarker for carcinomatosis in gastric cancer | HEPATO-GASTROENTEROLOGY |
| 2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | CANCER LETTERS |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | BIOCHEMICAL PHARMACOLOGY |
| 2007 | Molecular basis of the differences between normal and tumor tissues of gastric cancer | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE |
| 2001 | Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer | CANCER LETTERS |
| 2007 | Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations
| ONCOLOGIST |
| 2022 | Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysis | JOURNAL OF CLINICAL ONCOLOGY |
| 2018 | Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
| BMC CANCER |
| 2005 | Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis
| ANNALS OF ONCOLOGY |
| 2007 | Novel and simple transformation algorithm for combining microarray data sets
| BMC BIOINFORMATICS |
| 2024 | Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2009 | Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma. | CHEMOTHERAPY |
| 2021 | p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer | BIOCHEMICAL PHARMACOLOGY |
| 2021 | Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial
| ESMO OPEN |
| 2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2014 | Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2008 | Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
| ANNALS OF ONCOLOGY |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2008 | Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma. | ANTI-CANCER DRUGS |
| 2008 | Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up.
| ANNALS OF ONCOLOGY |
| 2021 | PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer | EXPERIMENTAL CELL RESEARCH |
| 2009 | Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2022 | Pre-treatment Nutritional Risk Assessment by NRS-2002 Predicts Prognosis in Patients With Advanced Biliary Tract Cancer: A Single Center Retrospective Study
| Clinical Nutrition Research |
| 2009 | Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery. | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2013 | Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
| BMC CANCER |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | ANTI-CANCER DRUGS |
| 2023 | Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
| CELL REPORTS MEDICINE |
| 2009 | Prognosis of pN3 stage gastric cancer
| CANCER RESEARCH AND TREATMENT |
| 2017 | Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
| CANCER RESEARCH AND TREATMENT |
| 2007 | Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single Institute | JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.
| CANCER RESEARCH AND TREATMENT |
| 2020 | Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients
| FRONTIERS IN ONCOLOGY |
| 2018 | Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
| FRONTIERS IN ONCOLOGY |
| 2006 | Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase
| FEBS LETTERS |
| 2007 | Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents | ONCOLOGY REPORTS |
| 2005 | Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2021 | Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
| FRONTIERS IN ONCOLOGY |
